116 related articles for article (PubMed ID: 32141426)
1. Ultrasound versus clinical joint level assessment to predict structural damage in rheumatoid arthritis patients receiving biological therapy: a prospective study.
Minowa K; Ogasawara M; Matsuki-Muramoto Y; Kawamoto T; Yamaji K; Tamura N
Clin Exp Rheumatol; 2020; 38(4):801. PubMed ID: 32141426
[No Abstract] [Full Text] [Related]
2. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
Ciubotariu E; Gabay C; Finckh A;
J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors for radiographic progression of large joint damage in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs (bDMARDs): Results of 3 to 4 years of follow-up.
Nakajima A; Terayama K; Sonobe M; Aoki Y; Takahashi H; Akatsu Y; Taniguchi S; Yamada M; Kubota A; Nakagawa K
Mod Rheumatol; 2019 Nov; 29(6):903-909. PubMed ID: 30285585
[No Abstract] [Full Text] [Related]
4. Structural joint damage and hand bone loss in patients with rheumatoid arthritis.
Ørnbjerg LM
Dan Med J; 2018 Mar; 65(3):. PubMed ID: 29510810
[TBL] [Abstract][Full Text] [Related]
5. Failure to control progression of rheumatoid arthritis after a decade of biologic therapy.
Scheinberg M; Filippi RZ; Hands R; Pitzalis C
J Rheumatol; 2012 Oct; 39(10):2049-50. PubMed ID: 23028032
[No Abstract] [Full Text] [Related]
6. Radiographic progression of large joint damage in patients with rheumatoid arthritis treated with biological disease-modifying anti-rheumatic drugs.
Nakajima A; Aoki Y; Sonobe M; Takahashi H; Saito M; Terayama K; Nakagawa K
Mod Rheumatol; 2016 Jul; 26(4):517-21. PubMed ID: 26473376
[TBL] [Abstract][Full Text] [Related]
7. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.
Aletaha D; Smolen JS
Arthritis Rheum; 2011 Dec; 63(12):3702-11. PubMed ID: 21953215
[TBL] [Abstract][Full Text] [Related]
8. [Proposal for biologic drugs therapy in rheumatoid arthritis].
Curković B; Babić-Naglić D; Morović-Vergles J; Anić B; Grazio S; Kaliterna DM; Hanih M; Novak S
Reumatizam; 2010; 57(1):29-35. PubMed ID: 20941938
[TBL] [Abstract][Full Text] [Related]
9. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression.
Brown AK; Quinn MA; Karim Z; Conaghan PG; Peterfy CG; Hensor E; Wakefield RJ; O'Connor PJ; Emery P
Arthritis Rheum; 2006 Dec; 54(12):3761-73. PubMed ID: 17133543
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?
Janta I; Valor L; De la Torre I; Martínez-Estupiñán L; Nieto JC; Ovalles-Bonilla JG; Martínez-Barrio J; Bello N; Hinojosa M; Montoro M; González CM; López-Longo J; Monteagudo I; Carreño L; Naredo E
Rheumatol Int; 2016 Mar; 36(3):387-96. PubMed ID: 26712373
[TBL] [Abstract][Full Text] [Related]
11. Optimizing therapy in inflammatory arthritis: prediction of relapse after tapering or stopping treatment for rheumatoid arthritis patients achieving clinical and radiological remission.
El Miedany Y; El Gaafary M; Youssef S; Ahmed I; Bahlas S; Hegazi M; Nasr A
Clin Rheumatol; 2016 Dec; 35(12):2915-2923. PubMed ID: 27658417
[TBL] [Abstract][Full Text] [Related]
12. [The use of ultrasound to assess the extent of inflammation in rheumatoid arthritis].
Hammer HB
Ultraschall Med; 2010 Aug; 31(4):437-8. PubMed ID: 20725899
[No Abstract] [Full Text] [Related]
13. Rheumatoid arthritis: are current research-based guidelines clinically relevant?
Kafaja S; Furst DE
J Rheumatol; 2014 Aug; 41(8):1569-70. PubMed ID: 25086136
[No Abstract] [Full Text] [Related]
14. Guidelines for the drug treatment of rheumatoid arthritis.
Mota LM; Cruz BA; Brenol CV; Pereira IA; Rezende-Fronza LS; Bertolo MB; Freitas MV; Silva NA; Louzada-Junior P; Giorgi RD; Lima RA; Bernardo WM; Pinheiro Gda R;
Rev Bras Reumatol; 2013 Apr; 53(2):158-83. PubMed ID: 23856794
[No Abstract] [Full Text] [Related]
15. Glucocorticoid Effect on Radiographic Progression in Placebo Arms of Rheumatoid Arthritis Biologics Trials.
Boers M; Aletaha D; Mela CM; Baker DG; Smolen JS
J Rheumatol; 2016 Jun; 43(6):1024-6. PubMed ID: 27036379
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of radiographic joint damage in rheumatoid arthritis patients in DAS28 remission using single- or combined with methotrexate non biological disease-modifying antirheumatic drug therapy in routine clinical practice.
Katayama K; Okubo T; Sato T; Ito H; Fukai R; Baba H
Mod Rheumatol; 2015 Jan; 25(1):50-5. PubMed ID: 24983407
[TBL] [Abstract][Full Text] [Related]
17. Early and aggressive treatment affects the association of HLA-DRB1 genes with progression of joint damage: comment on the article by Lard et al.
Rau R; Herborn G; Fenner H
Arthritis Rheum; 2003 Feb; 48(2):579. PubMed ID: 12571873
[No Abstract] [Full Text] [Related]
18. Modelling the cost-effectiveness of combination therapy for early, rapidly progressing rheumatoid arthritis by simulating the reversible and irreversible effects of the disease.
Stephens S; Botteman MF; Cifaldi MA; van Hout BA
BMJ Open; 2015 Jun; 5(6):e006560. PubMed ID: 26059521
[TBL] [Abstract][Full Text] [Related]
19. Using targeted therapies alone for rheumatoid arthritis.
Prati C; Wendling D
Joint Bone Spine; 2011 Jan; 78(1):1-3. PubMed ID: 21123101
[No Abstract] [Full Text] [Related]
20. Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression.
Naredo E; Collado P; Cruz A; Palop MJ; Cabero F; Richi P; Carmona L; Crespo M
Arthritis Rheum; 2007 Feb; 57(1):116-24. PubMed ID: 17266071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
